Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a …
…, M Ye, J Huang, X Zhi, Y Zhang, Q Xiu, J Ma… - The lancet …, 2011 - thelancet.com
Background Activating mutations in EGFR are important markers of response to tyrosine
kinase inhibitor (TKI) therapy in non-small-cell lung cancer (NSCLC). The OPTIMAL study …
kinase inhibitor (TKI) therapy in non-small-cell lung cancer (NSCLC). The OPTIMAL study …
Soft combination and detection for cooperative spectrum sensing in cognitive radio networks
In this letter, we consider cooperative spectrum sensing based on energy detection in cognitive
radio networks. Soft combination of the observed energies from different cognitive radio …
radio networks. Soft combination of the observed energies from different cognitive radio …
Asymmetric construction of stereogenic carbon centers featuring a trifluoromethyl group from prochiral trifluoromethylated substrates
Organofluorine chemistry is an area of tremendous expansion. 1 The field of applications is
impressively wide in scope and has the potential to concern all fields of society. Indeed, …
impressively wide in scope and has the potential to concern all fields of society. Indeed, …
Nasopharyngeal carcinoma
YP Chen, ATC Chan, QT Le, P Blanchard, Y Sun, J Ma - The Lancet, 2019 - thelancet.com
Nasopharyngeal carcinoma is characterised by distinct geographical distribution and is
particularly prevalent in east and southeast Asia. Epidemiological trends in the past decade …
particularly prevalent in east and southeast Asia. Epidemiological trends in the past decade …
Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients
…, L Zhou, ZW Fang, YT Wang, J Ma… - Blood, The Journal …, 1997 - ashpublications.org
The therapeutic effect of arsenic trioxide (As 2 O 3 ) in the treatment of acute promyelocytic
leukemia (APL) was evaluated among 15 APL patients at relapse after all-trans retinoic acid (…
leukemia (APL) was evaluated among 15 APL patients at relapse after all-trans retinoic acid (…
The placenta harbors a unique microbiome
Humans and their microbiomes have coevolved as a physiologic community composed of
distinct body site niches with metabolic and antigenic diversity. The placental microbiome has …
distinct body site niches with metabolic and antigenic diversity. The placental microbiome has …
Asymmetric fluorination, trifluoromethylation, and perfluoroalkylation reactions
Very few fields in chemistry have shown such a considerable interest as fluoroorganic
chemistry. Fluorine is perhaps the element that has experienced the greatest recent interest as …
chemistry. Fluorine is perhaps the element that has experienced the greatest recent interest as …
[HTML][HTML] Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma
…, YQ Li, MLK Chua, FY Xie, Y Sun, J Ma - … England Journal of …, 2019 - Mass Medical Soc
Background Platinum-based concurrent chemoradiotherapy is the standard of care for patients
with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine and …
with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine and …
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal …
…, YP Mao, LL Tang, YM Chen, MZ Liu, J Ma - The lancet …, 2012 - thelancet.com
Background The effect of the addition of adjuvant chemotherapy to concurrent chemoradiotherapy
in locoregionally advanced nasopharyngeal carcinoma is unclear. We aimed to …
in locoregionally advanced nasopharyngeal carcinoma is unclear. We aimed to …
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a …
…, F Zhang, L Lin, LL Tang, MZ Liu, J Ma - The lancet …, 2016 - thelancet.com
Background The value of adding cisplatin, fluorouracil, and docetaxel (TPF) induction
chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal …
chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal …